“cancer” Archives

in
Entry Author Date Location
Roundup: J&J and AT&T Grow in Houston, Inspyr and Meshify Move On 10/19/16 Texas
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns 10/03/16 Boston
Gates Grant Helps Sirenas Extend Hunt for Drugs From Sea Organisms 10/03/16 San Diego
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
The Future of Innovation at Xconomy’s Upcoming Disruptors Event 09/28/16 Texas
Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup 09/27/16 San Diego
In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial 09/23/16 San Diego
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
With $163M Deal, Tarveda Revives Synta Pharma’s Cancer Drug Work 09/19/16 Boston
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion 09/14/16 Boston
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
UC San Diego Nobel Laureate Roger Tsien Dies at 64 09/01/16 San Diego
Roundup: S3 Ventures, TMCx, George Peoples, Disruptors in Houston 08/25/16 Texas
Presenting Texas Disruptors, Oct. 27: DePinho, Metcalfe, Saxena & More 08/24/16 Texas
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
Governments Pay for Research, Jobs in San Antonio Tech and Science 08/18/16 Texas
Roundup: FloSports, Aidant, Tech Wildcatters, Bayou Startup Showcase 08/17/16 Texas
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
From Drugs to Data, Student Founders at Rice, UH Make Their Pitches 08/11/16 Texas
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff 08/08/16 San Diego
Dauntless Takes Flight with New Business Model for Starting Biotechs 07/21/16 San Diego
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
The Pan-Cancer Screen: Still Early for Prime Time 07/18/16 Boston
Xbiotech Responds to ESMO, Other Critics of Phase 3 Cancer Data 07/15/16 Texas
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Tissue Analyzer 3Scan Builds Out Machine Learning With $14M Series B 07/11/16 San Francisco
Page 2 of 65 « previous page · next page »